PubMed:33754144 / 893-1057
Annnotations
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-164 | Sentence | denotes | Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo. |
T9 | 0-164 | Sentence | denotes | Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo. |
yangbin123xm_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 98-110 | CI | denotes | mavrilimumab |
T10 | 156-163 | CI | denotes | placebo |
chenxin_473849_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 156-163 | CI | denotes | placebo |
T6 | 98-110 | CI | denotes | mavrilimumab |